| アブストラクト | To detect the gender variations in adverse events (AEs) of voriconazole, promote personalised medicine.A normalized dataset from Q1 2004 to Q4 2022 from the US Food and Drug Administration's Adverse Event Reporting System (FAERS) was analyses. The reporting odds ratio (ROR), proportional reporting ratio (PRR), and P value were used to examine data from the FAERS database to detect risk signals and quantify the presence and extent of gender variations in voriconazole adverse events.A total of 7670 cases (female/male (2785/4885)) of adverse reactions to voriconazole were analysed, and drug interaction (ROR 1.30 (1.10,1.54)), death and sudden death (ROR 1.31 (1.06,1.61)), actinic keratosis (ROR 1.98 (1.10,3.57)) were found to be significantly more frequent in male patients than in female patients.We found that gender was a determinant in voriconazole-related AEs using FAERS. Our results require future validation due to the inherent limits of this open data source, but they also identify potential contributing elements for a customised side effect profiling. |
|---|
| ジャーナル名 | Drug research |
|---|
| Pubmed追加日 | 2025/4/29 |
|---|
| 投稿者 | Xu, Qiong; Cheng, Hongxia; Sun, Xu; Zhao, Jing; Chen, Yingying; Ji, Lingyu; Liang, Yan |
|---|
| 組織名 | Department of Hematology, Shanxi Bethune Hospital, Shanxi Academy of Medical;Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University,;Taiyuan, China.;Department of Orthopedics, Shanxi Bethune Hospital, Shanxi Academy of Medical |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/40294598/ |
|---|
